|
Market Closed -
Hong Kong S.E.
04:08:07 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 21.22 HKD | +1.82% |
|
-7.09% | -30.38% |
| 08-27 | Medtide Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-31 | Medtide Names CFO | MT |
Projected Income Statement: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net sales 1 | 570.1 | 635.6 | 807.3 | 984.9 |
| Change | - | 11.5% | 27% | 22% |
| EBITDA 1 | 240.2 | 266.9 | 352 | 420.2 |
| Change | - | 11.09% | 31.92% | 19.36% |
| EBIT 1 | 212.4 | 232 | 302.7 | 376.2 |
| Change | - | 9.23% | 30.48% | 24.28% |
| Interest Paid | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Change | - | - | - | - |
| Net income | - | - | - | - |
| Change | - | - | - | - |
| Announcement Date | 3/30/26 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net Debt 1 | -857 | -693 | -802 | -914 |
| Change | - | 19.16% | -15.73% | -13.97% |
| Announcement Date | 3/30/26 | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: Medtide Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| CAPEX 1 | 40.13 | 92.15 | 55.18 | 21.02 | 128.4 |
| Change | - | 129.63% | -40.12% | -61.9% | 510.89% |
| Free Cash Flow (FCF) 1 | - | 14.41 | 8.273 | -3.381 | 69.14 |
| Change | - | - | -42.61% | -140.87% | 2,144.94% |
| Announcement Date | 12/6/24 | 12/6/24 | 12/6/24 | 6/20/25 | 4/23/26 |
1CNY in Million
Estimates
Forecast Financial Ratios: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | 42.14% | 41.98% | 43.61% | 42.66% |
| EBIT Margin (%) | 37.26% | 36.5% | 37.5% | 38.2% |
| EBT Margin (%) | - | - | - | - |
| Net margin (%) | - | - | - | - |
| FCF margin (%) | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - |
Profitability | ||||
| ROA | - | - | - | - |
| ROE | 23.3% | 12.96% | 14.6% | 15.37% |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | - | - | - |
| Debt / Free cash flow | - | - | - | - |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | - |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | 11.87 | 13.51 | 15.64 | 18.25 |
| Change | - | 13.82% | 15.77% | 16.69% |
| EPS 1 | - | - | - | - |
| Change | - | - | - | - |
| Nbr of stocks (in thousands) | 141,800 | 141,800 | 141,800 | 141,800 |
| Announcement Date | 3/30/26 | - | - | - |
1CNY
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | - | - |
| PBR | 1.32x | 1.14x |
| EV / Sales | 2.97x | 2.2x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
18.19CNY
Average target price
23.26CNY
Spread / Average Target
+27.86%
Net sales - Rate of surprise
- Stock Market
- Stocks
- 3880 Stock
- Financials Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
